These findings confirm that TNFRSF18 and CXCL13 both serve as biomarkers for exhausted CD8+ T cells in CRC samples, while TNFRSF18 exhibits more prominent predictive performance. This evidence concerns the gene CD8A and colorectal carcinoma.